Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery-Reference-Cited by-同舟云学术

Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery

Published:2022-04-29 Issue:11 Volume:33 Page:2018-2034
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Olshefsky Audrey¹²^ORCID,Richardson Christian¹²^ORCID,Pun Suzie H.¹³^ORCID,King Neil P.²⁴

Affiliation:

1. Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States

2. Institute for Protein Design, University of Washington, Seattle, Washington 98195, United States

3. Molecular Engineering and Sciences Institute, University of Washington, Seattle, Washington 98195, United States

4. Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States

Funder

Division of Chemistry

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Division of Graduate Education

Audacious Project

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.2c00030

Reference185 articles.

1. Engineering precision nanoparticles for drug delivery

2. Nanoparticle therapeutics: an emerging treatment modality for cancer

3. A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form

4. Doxil® — The first FDA-approved nano-drug: Lessons learned

5. Office of the Commissioner. FDA approves first COVID-19 vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine (accessed 2021 −11 −02).

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD13-targeting and TRAIL-displaying protein nanoparticles effectively induce apoptotic cell death of acute myeloid leukemia, prolonging survival in mouse models;Nano Today;2024-12

2. Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection;Frontiers in Immunology;2024-09-11

3. Therapeutic applications of cell engineering using mRNA technology;Trends in Biotechnology;2024-08

4. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies;Cell Reports Medicine;2024-07

5. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance;Drug Resistance Updates;2024-07